Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study ; volume:12 ; number:1 ; day:19 ; month:11 ; year:2019 ; pages:1-5 ; date:12.2019
Journal of hematology & oncology ; 12, Heft 1 (19.11.2019), 1-5, 12.2019
- Creator
-
Ramassone, Alice
D’Argenio, Andrea
Veronese, Angelo
Basti, Alessio
Soliman, Shimaa Hassan AbdelAziz
Volinia, Stefano
Bassi, Cristian
Pagotto, Sara
Ferracin, Manuela
Lupini, Laura
Saccenti, Elena
Balatti, Veronica
Pepe, Felice
Rassenti, Laura Z.
Innocenti, Idanna
Autore, Francesco
Marzetti, Laura
Mariani-Costantini, Renato
Kipps, Thomas J.
Negrini, Massimo
Laurenti, Luca
Visone, Rosa
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-019-0802-x
- URN
-
urn:nbn:de:101:1-2020031518482210306925
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ramassone, Alice
- D’Argenio, Andrea
- Veronese, Angelo
- Basti, Alessio
- Soliman, Shimaa Hassan AbdelAziz
- Volinia, Stefano
- Bassi, Cristian
- Pagotto, Sara
- Ferracin, Manuela
- Lupini, Laura
- Saccenti, Elena
- Balatti, Veronica
- Pepe, Felice
- Rassenti, Laura Z.
- Innocenti, Idanna
- Autore, Francesco
- Marzetti, Laura
- Mariani-Costantini, Renato
- Kipps, Thomas J.
- Negrini, Massimo
- Laurenti, Luca
- Visone, Rosa
- SpringerLink (Online service)
Other Objects (12)
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
Either, Rupert
Either, Rupert
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection
Imum, Continuatio CLL. Gryphiorum.
Untreated Classic Galactosemia: A Rare Cause of Adult-Onset Progressive Cerebellar Ataxia – A Case Report
Not bad judgement either
Movement from either direction
Either/Or In Chinatown
It could be either
Either...Or../ Entweder... oder
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
Either, Rupert
Either, Rupert
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection
Imum, Continuatio CLL. Gryphiorum.
Untreated Classic Galactosemia: A Rare Cause of Adult-Onset Progressive Cerebellar Ataxia – A Case Report
Not bad judgement either
Movement from either direction
Either/Or In Chinatown
It could be either
Either...Or../ Entweder... oder
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
Either, Rupert
Either, Rupert
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection
Imum, Continuatio CLL. Gryphiorum.
Untreated Classic Galactosemia: A Rare Cause of Adult-Onset Progressive Cerebellar Ataxia – A Case Report
Not bad judgement either
Movement from either direction
Either/Or In Chinatown
It could be either